Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Anusha Muralidhar"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 5 (2024)
Rationale Androgen deprivation therapy (ADT) is the primary treatment for recurrent and metastatic prostate cancer. In addition to direct antitumor effects, ADT has immunomodulatory effects such as promoting T-cell infiltration and enhancing antigen
Externí odkaz:
https://doaj.org/article/6ee9ae85e74447c8bc6ad9989ced5b16
Autor:
Douglas G McNeel, Zachary S Morris, Reinier Hernandez, Jamey P Weichert, Anusha Muralidhar, Hansel Comas Rojas, Malick Bio Idrissou
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 4 (2024)
Rationale Androgen deprivation therapy (ADT) is pivotal in treating recurrent prostate cancer and is often combined with external beam radiation therapy (EBRT) for localized disease. However, for metastatic castration-resistant prostate cancer, EBRT
Externí odkaz:
https://doaj.org/article/27673128e2c04b24a1157868424e0536
Autor:
Douglas McNeel, Anusha Muralidhar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/85759d3c8eff476d9629018894a55094
Autor:
Ichwaku Rastogi, Donghwan Jeon, Jena E. Moseman, Anusha Muralidhar, Hemanth K. Potluri, Douglas G. McNeel
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
B cells have been long studied for their role and function in the humoral immune system. Apart from generating antibodies and an antibody-mediated memory response against pathogens, B cells are also capable of generating cell-mediated immunity. It ha
Externí odkaz:
https://doaj.org/article/186693e6e8594177b96448fdb34d28e4
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 252 (2023)
Prostate cancer is the most diagnosed malignancy in men in the United States and the second leading cause of cancer-related death. For localized disease, radiation therapy is a standard treatment that is often curative. For metastatic disease, radiat
Externí odkaz:
https://doaj.org/article/27dff2cf52724378a25bba05d8e4800f
Publikováno v:
Nature Reviews Urology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fac025fd8701ea9c6d273915255c323c
https://doi.org/10.1038/s41585-023-00739-w
https://doi.org/10.1038/s41585-023-00739-w
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4913733e45763c6e4b2a680cda678cec
https://doi.org/10.1136/jitc-2022-sitc2022.0893
https://doi.org/10.1136/jitc-2022-sitc2022.0893
Autor:
Douglas G. McNeel, Laura E. Johnson, Hemanth Potluri, Ellen Wargowski, Donghwan Jeon, Melissa Gamat-Huber, Anusha Muralidhar, Christopher D. Zahm, Ichwaku Rastogi, Jena E Moseman
Publikováno v:
Cancers
Cancers, Vol 12, Iss 2831, p 2831 (2020)
Cancers, Vol 12, Iss 2831, p 2831 (2020)
Simple Summary The only vaccine approved by FDA as a treatment for cancer is sipuleucel-T, a therapy for patients with metastatic castration-resistant prostate cancer (mCRPC). Most investigators studying anti-tumor vaccines believe they will be most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5825349bdf963fc787d726f9169ef8
https://pubmed.ncbi.nlm.nih.gov/33008010
https://pubmed.ncbi.nlm.nih.gov/33008010